Company news
Avacta Group PLC news in 2021
Avacta Group PLC's news releases, calls and decks from 2021, newest first.
AffiDX Receives CE Mark for Consumer Self-Testing
December 22, 2021
Change of auditor
December 15, 2021
AffiDx® lateral flow test detects Omicron variant
December 15, 2021
FDA Approval of IND Application for AVA6000
November 29, 2021
Update on UK Availability of AffiDX Test
November 2, 2021
Interim Results for the Period Ended 30 June 2021
September 30, 2021
Development Milestone in LG Chem Partnership
September 29, 2021
New appointments to Scientific Advisory Board
September 6, 2021
Appointment of Chief Scientific Officer
September 2, 2021
First Patient Dosed in AVA6000 Phase 1 Trial
August 11, 2021
Update on AffiDX Lateral Flow Test
August 4, 2021
Diagnostics achieves ISO 13485 Certification
July 14, 2021
AffiDX Lateral Flow Test Detects Delta Variant
June 29, 2021
AffiDX Lateral Flow Test Distribution Agreement
June 21, 2021
Registration of AffiDX Lateral Flow Test in EU
June 11, 2021
Holding(s) in Company
June 9, 2021
MHRA Confirms Registration of Lateral Flow Test
June 7, 2021
Update on Lateral Flow Test Regulatory Submissions
June 1, 2021
Response to speculation
May 28, 2021
AffiDX SARS-CoV-2 Antigen Lateral Flow Test Update
May 10, 2021
Change of Nominated Adviser
May 6, 2021
Final Results
April 22, 2021
Clinical validation of AffiDX Lateral Flow Test
April 20, 2021
Distribution Agreement with ABCAM plc
April 6, 2021
Diagnostic Licensing Deal with Biokit
March 9, 2021
Rapid Antigen Test Detects SARS-CoV-2 Variants
March 8, 2021
Electronic Communications with Shareholders
March 3, 2021
Business Update
February 24, 2021
Re: Press Speculation
February 22, 2021
Phase I CTA for AVA6000 Approved by MHRA
February 18, 2021
Results of Initial Evaluation of SARS-CoV-2 LFT
February 16, 2021
Commercial Partnership with Mologic
February 8, 2021
AffyXell $7.3 Million Series A Financing
February 1, 2021
Collaboration Agreement with Bruker
January 28, 2021
License Agreement with POINT Biopharma Inc.
January 7, 2021
Calls in 2021
Decks in 2021
- Immunotherapy World Congress 2021
Conference · 21 slides · November 2021
- H1 2021 Earnings Presentation
Earnings · 25 slides · Sep 30, 2021